Search

Search Constraints

You searched for: Author/Creator Plotnikov, Alexei

Search Results

1. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Issue 10081 (6th May 2017)

2. Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial. Issue 2 (1st March 2019)

3. Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial. Issue 2 (March 2019)

5. The treatment of missing data in a large cardiovascular clinical outcomes study. (June 2016)